PCV55 LIPID LOWERING AGENTS CONSUMPTION AND COSTS IN THE SLOVAK REPUBLIC

Consumption of Medicaments in the Slovak Republic

High consumption of medicaments places a heavy burden on public health systems. Several major national surveys have documented important increases in the misuse and abuse of several prescription drugs (1). Analysing consumption and prescription of drugs have been conducted in several studies (2, 3). This study aimed to analyze the consumption of individual classes of medicaments in the Slovak R...

Guideline on Lipid Lowering agents

Prescription Patterns and Costs of Lipid-lowering Agents in Northern Portugal – Analysis of Primary Care Data

Analysis of the direct and indirect costs of treatment of imported malaria in the Slovak Republic.

This study analyzed the approximate cost of treatment of patients hospitalized with a diagnosis of imported malaria in Slovakia. Between 2003 and 2007, 15 patients with imported malaria were hospitalized. The mean direct cost of the treatment was 970.75 euros and the mean indirect cost was 53.15 euros. For the patient with the highest cost of treatment, the use of mefloquine prophylaxis would h...

Novel Uses for Lipid-Lowering Agents

Statin use leads to a reduction in the downstream products of the mevalonate pathway. Knowledge of this pathway has led scientists to investigate the role of statins in cancer prevention and treatment. Statins appear to possess a variety of pleiotropic effects, including inhibition of cell proliferation; enhanced apoptosis; and modulation of inflammation, endothelial function, and angiogenesis....